Last updated: June 14, 2023
Sponsor: Chung Shan Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dry Eye Disease
Sjogren's Syndrome
Eyelid Inflammation
Treatment
Probiotics
Placebo
Clinical Study ID
NCT05906381
202300014B0
Ages 20-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- aged between 20 and 65 years
- with Schirmer's test results less than 10 mm or Ocular Surface Disease Index more than 25
Exclusion
Exclusion Criteria:
- evident ocular diseases such as cornea disease, cataract, vitreous degeneration,glaucoma, and retinopathy.
- diabetes
- hypertension
- or other chronic diseases or belong to vulnerable groups(pregnancy woman, prisoner,ethical minorities, economic or educationally disadvantaged subjects, disabledindividuals such as those at terminal stage of tumorigenesis, blindness, terminal illindividuals)
Study Design
Total Participants: 88
Treatment Group(s): 2
Primary Treatment: Probiotics
Phase:
Study Start date:
May 13, 2023
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Jen-Ai Hospital
Taichung, 412
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.